THE EXPERT BOARD'S ABSTRACT ON QUESTIONS OF THE SURVIVAL OF BIOLOGICAL AGENTS AND THE POSSIBILITY OF SWITCHING TO SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICE
.
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2017-01-01
|
Series: | Научно-практическая ревматология |
Online Access: | http://rsp.ima-press.net/rsp/article/view/2369 |
_version_ | 1797719646403559424 |
---|---|
author | artilce Editorial |
author_facet | artilce Editorial |
author_sort | artilce Editorial |
collection | DOAJ |
description | . |
first_indexed | 2024-03-12T09:08:06Z |
format | Article |
id | doaj.art-9b15393e9cac44c19cc42f3b86415c69 |
institution | Directory Open Access Journal |
issn | 1995-4484 1995-4492 |
language | Russian |
last_indexed | 2024-03-12T09:08:06Z |
publishDate | 2017-01-01 |
publisher | IMA PRESS LLC |
record_format | Article |
series | Научно-практическая ревматология |
spelling | doaj.art-9b15393e9cac44c19cc42f3b86415c692023-09-02T15:10:04ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922017-01-015522302312226THE EXPERT BOARD'S ABSTRACT ON QUESTIONS OF THE SURVIVAL OF BIOLOGICAL AGENTS AND THE POSSIBILITY OF SWITCHING TO SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICEartilce Editorial.http://rsp.ima-press.net/rsp/article/view/2369 |
spellingShingle | artilce Editorial THE EXPERT BOARD'S ABSTRACT ON QUESTIONS OF THE SURVIVAL OF BIOLOGICAL AGENTS AND THE POSSIBILITY OF SWITCHING TO SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICE Научно-практическая ревматология |
title | THE EXPERT BOARD'S ABSTRACT ON QUESTIONS OF THE SURVIVAL OF BIOLOGICAL AGENTS AND THE POSSIBILITY OF SWITCHING TO SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICE |
title_full | THE EXPERT BOARD'S ABSTRACT ON QUESTIONS OF THE SURVIVAL OF BIOLOGICAL AGENTS AND THE POSSIBILITY OF SWITCHING TO SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICE |
title_fullStr | THE EXPERT BOARD'S ABSTRACT ON QUESTIONS OF THE SURVIVAL OF BIOLOGICAL AGENTS AND THE POSSIBILITY OF SWITCHING TO SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICE |
title_full_unstemmed | THE EXPERT BOARD'S ABSTRACT ON QUESTIONS OF THE SURVIVAL OF BIOLOGICAL AGENTS AND THE POSSIBILITY OF SWITCHING TO SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICE |
title_short | THE EXPERT BOARD'S ABSTRACT ON QUESTIONS OF THE SURVIVAL OF BIOLOGICAL AGENTS AND THE POSSIBILITY OF SWITCHING TO SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN REAL CLINICAL PRACTICE |
title_sort | expert board s abstract on questions of the survival of biological agents and the possibility of switching to secukinumab in ankylosing spondylitis in real clinical practice |
url | http://rsp.ima-press.net/rsp/article/view/2369 |
work_keys_str_mv | AT artilceeditorial theexpertboardsabstractonquestionsofthesurvivalofbiologicalagentsandthepossibilityofswitchingtosecukinumabinankylosingspondylitisinrealclinicalpractice AT artilceeditorial expertboardsabstractonquestionsofthesurvivalofbiologicalagentsandthepossibilityofswitchingtosecukinumabinankylosingspondylitisinrealclinicalpractice |